14 June 2023
Abbott Laboratories strengthens its financial leadership team with the appointment of Philip Boudreau as Chief Financial Officer, ensuring a robust strategy for sustainable growth in the healthcare industry.
Abbott Laboratories, a leading healthcare-products company based in Abbott Park, Illinois, has announced the appointment of Philip Boudreau as its new senior vice president of finance and chief financial officer (CFO), effective September 1. Boudreau, who currently serves as the company’s controller, will assume the CFO role and continue reporting to Robert Funck, Abbott’s executive vice president of finance and CFO since March 2020.
With this strategic decision, Abbott Laboratories aims to leverage Boudreau’s extensive financial expertise and his deep understanding of the company’s operations and financial landscape. Boudreau’s promotion is a testament to his exceptional contributions as the controller, where he demonstrated strong leadership and financial acumen.
As the incoming CFO, Boudreau will play a pivotal role in shaping Abbott Laboratories’ financial strategy and driving its long-term growth objectives. His experience in financial management and his familiarity with Abbott’s financial framework make him well-suited for this crucial position within the company.
Under the leadership of Robert Funck, Abbott Laboratories has witnessed significant achievements and maintained a strong financial standing. Funck’s continued role as the executive vice president of finance will ensure a smooth transition and enable seamless collaboration between him and Boudreau as they work together to steer the company forward.
To fill the vacancy left by Boudreau’s promotion, the company has also announced the promotion of John McCoy Jr. to the position of controller. McCoy, who has served in various finance-related roles at Abbott Laboratories, brings a wealth of experience and expertise to his new role. His appointment further strengthens the company’s financial leadership team and ensures the continuity of financial operations.
Abbott Laboratories remains committed to advancing healthcare solutions and improving the lives of people around the world. The strategic appointments of Boudreau as CFO and McCoy as controller reaffirm the company’s dedication to maintaining financial stability and pursuing sustainable growth in the ever-evolving healthcare industry.
With Boudreau’s wealth of knowledge, coupled with Funck’s continued guidance and support, Abbott Laboratories is well-positioned to navigate the complex financial landscape and capitalize on emerging opportunities. These appointments reflect the company’s confidence in its leadership team’s ability to drive innovation, deliver strong financial performance, and create long-term value for shareholders.
